Alnylam Pharmaceuticals, Inc.

529900S3ZI14OWRJII50

The entity

Status: Active
LEI status: Issued and current
Category: Company
Legal form: Corporation (XTIQ)
Jurisdiction: US-DE
Entity created: May 8, 2003

Address

Country: United States
Legal address: c/o The Corporation Trust Company, Corporation Trust Center 1209 Orange St19801 WilmingtonUnited States (US-DE)
Head office: 300 Third Street, 3rd Floor02142 CamebridgeUnited States (US-MA)

Identifier

LEI: 529900S3ZI14OWRJII50
Registered: October 19, 2018 at 09:10 AM UTC
Last updated: July 2, 2026 at 01:58 PM UTC
Next renewal: August 10, 2027 at 05:23 AM UTC
Issuer: WM Datenservice (5299000J2N45DDNE4Y28)
Registered with: Division of Corporations, Department of State (RA000602)
Identifier: 3651907
Verified against: Division of Corporations, Department of State (RA000602)
Verified as: 3651907
Corroboration: Confirmed against a public register
GLEIF conformity: Meets the standard

Corporate structure

Why no parent is reported

No direct parent reportedNo ultimate parent reported: No parent prepares consolidated accounts including it

Machine access

REST: https://lei.online/v1/entities/529900S3ZI14OWRJII50This record as JSON.
MCP: https://lei.online/mcpThe same data as an MCP tool.

Start a new search